Private Equity & Investment Funds
PRIVATE EQUITY & INVESTMENT FUNDS
Nixon Peabody is one of the leading firms in the world advising institutional investors, private equity funds, and portfolio companies. We are committed to helping clients manage risk and deploy capital in the middle and lower middle markets.
Over the past nine years, Private Equity Analyst has ranked Nixon Peabody among the most active law firms for private equity and venture capital transactions (#14 in 2013), as well as for fund formation and investments (#4 in 2013). In addition, our attorneys have been recognized as leaders in the field by Chambers USA: America’s Leading Lawyers for Business and U.S. News/Best Lawyers "Best Law Firms." In 2012, the firm was recognized by the Association for Corporate Growth (ACG) and M&A Advisor as the legal advisor of the “Middle Market Deal of the Year” as well as the “Cross-Border Deal of the Year.” This is the second year in a row we have advised on an award-winning deal.
We have a full-service platform offering advice across the spectrum of issues that can arise in the context of private equity investing, including:
- Fund formation and investments: we counsel general partners and limited partners in connection with fund structures, management issues, investments in new funds, and secondary sales
- Transactions: we represent sponsors in buyouts, minority investments, growth equity, recapitalizations, distressed acquisitions, and portfolio investment activities
- Litigation: we advise funds and managers in a variety of challenges, ranging from risk management to control contests to liquidation
While we have experience representing clients in transactions of all sizes, we are best known for our work in the middle market. We are better positioned than any other firm in the country to serve this segment of the market. The quality of our work is at the pinnacle of the legal profession, but our geographic footprint allows us to deliver value that regional or boutique firms can’t match.
Although we are sector agnostic in our approach, we have particularly deep and long-standing experience in the following areas:
- Consumer products (including food & beverage)
- Energy (traditional and renewable)
- Health care
- Higher education
- Life sciences (biotech and medical devices)
Our broad client base and range of experience affords us tremendous market knowledge. We can offer cutting-edge perspectives on market terms and pricing. We can also provide valuable advice on negotiating techniques that will fit key business objectives and the state of the credit and capital markets. Finally, we have an exceptional network of relationships and insight into proprietary investment opportunities. We leverage these connections to make strategic, relevant introductions through NP Capital Connector.
In order to provide highly integrated support and business-oriented solutions, we team up with colleagues from a variety of disciplines, including tax, leveraged finance, capital markets, corporate governance, intellectual property, ERISA, labor and employment, real estate, and environmental.
For leveraged transactions or those involving refinancing of debt, we work with the firm’s finance attorneys on a wide range of vehicles, including unsecured and secured lending, senior and mezzanine lending, derivatives, and securitizations.
- Annual Meetings Tip Toward Business, Less Pleasure
Buyouts | May 10, 2013
Partner and leader of the firm’s Private Equity & Investment Funds practice John Koeppel and Albany Private Equity & Investment Funds partner Todd Tidgewell discuss the current state of annual meetings for limited partners in the private equity industry.
- Export Controls Reform: Understanding the 600 Series
Law360 | May 2, 2013
A team of Washington, DC, attorneys, including Government Investigations & White Collar Defense partner Grayson Yeargin and associate Lindsey Nelson, Global Business & Transactions associate Alexandra Lopez-Casero, and Private Equity & Investment Funds associate Nick Rosenberg, co-authored this column discussing the introduction of the “600 series,” which changes the rules applicable to companies that have items listed on the U.S. Munitions List.
- Carlyle, KKR, TPG Raising Billions for China, But Deals May Be Scarce
Buyouts | April 29, 2013
Partner and leader of the firm’s China and Asia Pacific practice David Cheng discusses private equity deal trends in China.